149 related articles for article (PubMed ID: 6897542)
1. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
Piver MS; DeEulis TG; Lele SB; Barlow JJ
Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
[No Abstract] [Full Text] [Related]
2. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Hempling RE; Piver MS; Baker TR
Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Lynch G; Magill GB; Sordillo P; Golbey RB
Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced soft tissue sarcomas with a modified CYVADIC protocol.
Pfeffer MR; Sulkes A; Biran S
Oncology; 1984; 41(5):308-13. PubMed ID: 6548004
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.
Bui NB; Chauvergne J; Hocke C; Durand M; Brunet R; Coindre JM
Cancer Chemother Pharmacol; 1985; 15(1):82-5. PubMed ID: 3891123
[TBL] [Abstract][Full Text] [Related]
6. Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy.
Bodey GP; Rodriguez V; Murphy WK; Burgess A; Benjamin RS
Cancer; 1981 May; 47(10):2422-9. PubMed ID: 7272896
[TBL] [Abstract][Full Text] [Related]
7. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Bui B; Chauvergne J; Durand M; Brunet R
Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
[TBL] [Abstract][Full Text] [Related]
8. [Toxicity of the CYVADIC modification in patients with soft tissue sarcomas or malignant mesotheliomas].
Sauer H; Kremer G; Wilmanns W
Onkologie; 1987 Oct; 10(5):294-300. PubMed ID: 3317170
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
10. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.
Nakano K; Motoi N; Takahashi S
Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010
[TBL] [Abstract][Full Text] [Related]
11. Case report: bilateral recurrent tension pneumothorax complicating combination chemotherapy for soft tissue sarcoma.
Fenlon HM; Carney D; Breatnach E
Clin Radiol; 1996 Apr; 51(4):302-4. PubMed ID: 8617048
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy CYVADIC and adriamycin (injected intratumorally) result in a partial response for six months in uterine sarcoma recurrence].
Higashijima H; Yoh S; Kataoka A; Arimatsu T; Tanaka H; Araki T; Nishida K; Umezu J
Igaku Kenkyu; 1986 Jun; 56(2):77-84. PubMed ID: 3564864
[No Abstract] [Full Text] [Related]
13. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Piver MS; Lele SB; Marchetti DL; Emrich LJ
J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.
Karakousis CP; Rao U; Park HC
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):33-6. PubMed ID: 7200893
[TBL] [Abstract][Full Text] [Related]
15. Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
Presant CA; Lowenbraun S; Bartolucci AA; Smalley RV
Cancer; 1981 Feb; 47(3):457-65. PubMed ID: 7225999
[TBL] [Abstract][Full Text] [Related]
16. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
[TBL] [Abstract][Full Text] [Related]
17. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to CYVADIC combination therapy of soft tissue sarcomas.
Hartlapp JH; Münch HJ; Illiger HJ; Wolter H; Jensen JC
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S20-2. PubMed ID: 3815715
[TBL] [Abstract][Full Text] [Related]
19. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
Omura GA; Major FJ; Blessing JA; Sedlacek TV; Thigpen JT; Creasman WT; Zaino RJ
Cancer; 1983 Aug; 52(4):626-32. PubMed ID: 6344983
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
